SCHEMBL2655335

SCHEMBL2655335

Cc1cnc(NC(=O)c2cc(O)cc(OC(C)(C)O)c2)cn1

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GCK P35557 16/20 0.44
KCNH2 Q12809 6/20 0.43
DEGS1 O15121 2/20 0.40
NOTUM Q6P988 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2658141 0.84 GCK (0.43) GCKKCNH2
SCHEMBL1427361 0.83 GCK (0.51) GCKKCNH2
SCHEMBL2654780 0.82 CHRNB2 (0.48) GCKKCNH2
SCHEMBL1427229 0.79 GCK (0.64) GCKKCNH2
SCHEMBL4783311 0.79 GCK (0.64) GCKKCNH2
SCHEMBL2660380 0.78 GCK (0.65) GCKKCNH2
SCHEMBL1427033 0.78 GRM5 (0.53) GCK
SCHEMBL1427153 0.78 GCK (0.65) GCKKCNH2
SCHEMBL1776589 0.76 GRM5 (0.55)
SCHEMBL1653673 0.76 GCK (0.51) GCKKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756076-A1 HETROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES AstraZeneca AB (SE) 2007-02-28 EP disclosed
WO-2005121110-A1 HETROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES ASTRAZENECA AB (SE) 2005-12-22 WO disclosed